Skip to content
  • Sunday, 26 July 2026
  • 1:40 am
  • Follow Us
Lab DB
  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ
  • Home
  • Paternal Age and Genetic Risk: How Natural Selection Within the Testes Drives the Accumulation of Disease-Causing Mutations in Aging Men
Stem Cell & Regenerative Medicine

Paternal Age and Genetic Risk: How Natural Selection Within the Testes Drives the Accumulation of Disease-Causing Mutations in Aging Men

Dwi Wanna Jul 22, 2026 0

In a landmark set of studies published on October 8 in the journal Nature, researchers have unveiled a sophisticated biological…

Read More
Neuroscience & Brain Research

Breakthrough Research Reveals Lacunar Stroke Origins Linked to Artery Widening Rather Than Conventional Fatty Plaque Accumulation

Rifan Muazin Jul 18, 2026 0

A landmark study led by researchers at the University of Edinburgh and the UK Dementia Research Institute has challenged decades…

Read More
Turning Plastic Waste into Clean Energy The Global Shift Toward Solar Powered Chemical UpcyclingDragonfly Vision Unlocks New Frontiers in Medical Technology Through Parallel EvolutionWhat if psilocybin works about as well for depression as an SSRI?Immuto Scientific Pairs AI and Mass Spectrometry for a Step Change in Protein Structure Throughput
MEDVi Under Scrutiny: AI-Powered Telehealth Startup Faces FDA Warnings, Deceptive Marketing Allegations, and Multiple Lawsuits Despite Meteoric GrowthLLMOps in 2026: The 10 Tools Every Team Must HaveJapan’s FY26 NHI Drug Price Revision: Deeper Dive into Mechanisms and Market ImpactThe Most Favored Nation (MFN) Policy’s Unforeseen Ripple Effect: European Pharmaceutical Launches and Withdrawals Plummet
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’sKing’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid DecompositionSanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
YOU MAY HAVE MISSED
Laboratory Automation & Robotics
Remepy, a startup that pairs drugs with AI-driven apps, clears a Phase IIa test in Parkinson’s
Lana Keisha Jul 25, 2026
Neuroscience & Brain Research
King’s College London Researchers Identify Potential Breakthrough Alzheimer’s Treatment Through Repurposed Spinal Cord Injury Drug KCL-286
Rifan Muazin Jul 25, 2026
Advanced Materials Science
Living Plastics That Self-Destruct: Scientists Engineer Microbe-Embedded Polymers for Complete and Rapid Decomposition
Nila Kartika Wati Jul 25, 2026
Pharmaceutical R&D
Sanofi Discontinues Amlitelimab Development in Atopic Dermatitis, Citing Lack of Meaningful Differentiation
Teuku Ryan Jul 25, 2026

Copyright © 2025 | Powered by WordPress | News Gadgets by ThemeArile

  • Home
  • About Us
    • About Us
    • Affiliate Disclosure
    • Cookie Policy
    • Disclaimer
    • Privacy Policy
    • DMCA
    • Terms of Service
  • Contact Us
  • FAQ